
    
      This study is a single center, prospective exploratory pilot study of Sickle Cell Anemia
      (SCA) participants, age ≥18 years, with SCA. The study will enroll patients with early stages
      of sickle cell nephropathy (Chronic Kidney Disease (CKD) stage 1 or 2) who are at the highest
      risk of CKD progression (presence of both hemoglobinuria and urine albumin concentration ≥ 30
      mg/g creatinin
    
  